ACEINTEG - Ace Integrated
📢 Recent Corporate Announcements
Ace Integrated Solutions Limited reported a severe decline in performance for Q3 FY26, with revenue from operations falling to just ₹11 Lakhs from ₹143 Lakhs YoY. The company recorded a net loss of ₹27 Lakhs for the quarter, compared to a loss of ₹21 Lakhs in the previous year's corresponding quarter. For the nine-month period ended December 2025, total income stood at ₹118 Lakhs, down from ₹729 Lakhs in the previous year. Notably, the company's core segments like Examination and Printing reported zero revenue, with the only activity coming from Speciality Chemicals and a new Property services segment.
- Revenue from operations plummeted 92.3% YoY to ₹11 Lakhs in Q3 FY26.
- Net loss for the quarter widened to ₹27 Lakhs from ₹21 Lakhs in the same period last year.
- Nine-month revenue fell to ₹118 Lakhs from ₹711 Lakhs, reflecting a massive business slowdown.
- Core segments (Examination and Printing) generated zero revenue during the quarter.
- Recognized an exceptional loss of ₹2.39 Lakhs due to the impact of New Labour Codes.
Ace Integrated Solutions Limited reported a sharp decline in its financial performance for the quarter ended September 30, 2025. Revenue from operations collapsed to ₹17 Lakhs from ₹316 Lakhs in the corresponding quarter of the previous year. The company posted a net loss of ₹4 Lakhs for the quarter, despite a significant contribution from 'Other Income' amounting to ₹33 Lakhs. For the first half of the fiscal year (H1 FY26), the company recorded a total loss of ₹34 Lakhs compared to a profit of ₹4 Lakhs in H1 FY25.
- Revenue from operations crashed by 94.6% YoY to ₹17 Lakhs in Q2 FY26.
- Reported a net loss of ₹4 Lakhs in Q2 FY26 against a profit of ₹1 Lakh in Q2 FY25.
- Other Income of ₹33 Lakhs in Q2 included a one-time write-back of ₹27.82 Lakhs from a vendor claim.
- H1 FY26 total income stood at ₹101 Lakhs, down from ₹580 Lakhs in H1 FY25.
- The company identified a new reportable segment: Property and related services.
Ace Integrated Solutions Limited has submitted its quarterly compliance certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018. The certificate, provided by Bigshare Services Private Limited, confirms the processing of dematerialization requests for the quarter ended December 31, 2025. It ensures that physical share certificates were mutilated and cancelled, with depository names updated in the register within 30 days. This filing is a standard regulatory requirement for listed entities to ensure the integrity of shareholding records.
- Compliance certificate submitted for the quarter ended December 31, 2025
- Bigshare Services Private Limited acted as the Registrar & Share Transfer Agent
- Confirmed that dematerialized shares are listed on the National Stock Exchange
- Physical certificates were processed and cancelled within the 30-day regulatory timeframe
Ace Integrated Solutions Limited has announced the closure of its trading window effective January 1, 2026, in compliance with SEBI Insider Trading regulations. This closure is ahead of the consideration of the un-audited standalone financial results for the quarter ending December 31, 2025. The window will remain closed for all designated persons, including directors and promoters, until 48 hours after the results are declared. The specific date for the board meeting to approve these results will be announced at a later date.
- Trading window closure starts on January 1, 2026, for the quarter ending December 31, 2025.
- Applies to all Directors, Promoters, Designated Persons, and Senior Management Personnel.
- Window remains closed until 48 hours post-announcement of un-audited standalone financial results.
- Board meeting date for result declaration to be intimated in due course.
Ace Integrated Solutions Limited has announced the closure of its trading window starting January 1, 2026, in compliance with SEBI (Prohibition of Insider Trading) Regulations. This closure is ahead of the consideration and approval of the un-audited Standalone Financial Results for the quarter ending December 31, 2025. The restriction applies to all Directors, Promoters, and Senior Management Personnel, including their immediate relatives. The trading window will reopen 48 hours after the financial results are officially declared to the exchange.
- Trading window closure effective from January 1, 2026.
- Closure pertains to the un-audited Standalone Financial Results for the quarter ended December 31, 2025.
- Window will remain closed until 48 hours after the results are announced.
- Applies to all designated persons including Directors, Promoters, and Senior Management.
- The specific date for the Board Meeting to declare results will be announced separately.
Financial Performance
Revenue Growth by Segment
Not disclosed in absolute INR; however, the company reported a significant decline in profitability with Operating Profit Margin dropping from 5% in FY24 to -24.42% in FY25, a variance of -641% due to losses in the chemical product domain.
Geographic Revenue Split
Not disclosed in available documents; however, the company operates large-scale country-wide Examination Management projects across India.
Profitability Margins
Operating Profit Margin declined to -24.42% from 5% (down 641% YoY). Net Profit Margin fell to -18% from 5% (down 505% YoY). Return on Net Worth dropped to -9% from 2% (down 511% YoY).
EBITDA Margin
Operating Profit Margin of -24.42% in FY25 compared to 5% in FY24, representing a -641% variance primarily due to narrowed margins in the chemical trading segment and overall losses.
Capital Expenditure
Not disclosed in absolute INR Cr; however, the company has decided to cease further stocking of indigenous chemical products in the upcoming year to preserve capital.
Credit Rating & Borrowing
The company notes that any downgrading of India’s sovereign rating would adversely impact its ability to raise financing and increase interest rates. Debt Equity Ratio remained stable at 0.01 in FY25.
Operational Drivers
Raw Materials
Indigenous chemicals (specific names not disclosed) represent the primary product/input that impacted margins due to unexpected market competition.
Capacity Expansion
Not disclosed in available documents; however, the company is pivoting away from chemical stocking due to a 'meagre' product market.
Raw Material Costs
Not disclosed as a % of revenue; however, margins narrowed significantly in FY25 due to the introduction of indigenous chemicals which disrupted expected market growth.
Manufacturing Efficiency
Inventory Turnover Ratio was 8.63 in FY25 compared to 8.77 in FY24 (a 2% decrease), reflecting a cautious approach to stocking after previous years of overstocking.
Logistics & Distribution
Logistics are a critical component of the Examination Management projects; errors in logistics are cited as a major operational risk that could limit growth.
Strategic Growth
Growth Strategy
The company plans to achieve growth by focusing on brand building for ACEINTEG to compete effectively in the examination management industry. It is also strategically exiting or reducing its exposure to the chemical stocking domain where margins have narrowed, while maintaining a robust internal control and corporate governance framework to attract stakeholders.
Products & Services
Examination Management services (pre-examination and post-examination activities), logistics for large-scale exams, and chemical products (currently being phased out/reduced).
Brand Portfolio
ACEINTEG
External Factors
Industry Trends
The examination management industry is evolving with a focus on logistics and pre/post-exam coordination. The chemical trading industry is seeing disruption from indigenous products, leading the company to exit this 'meagre' market segment.
Competitive Landscape
Faces competition from indigenous chemical providers and other examination management service providers; brand recognition is cited as a key competitive requirement.
Competitive Moat
The company relies on its brand 'ACEINTEG' and its legacy in examination management. However, the lack of proprietary technology or high switching costs is not detailed, and the moat appears vulnerable to regulatory changes and competition.
Macro Economic Sensitivity
Highly sensitive to interest rate fluctuations and India's sovereign credit rating, which directly impact borrowing terms and financial performance.
Consumer Behavior
Market growth for certain products was lower than expected in FY25 due to 'cautious behavior' and shifts toward indigenous alternatives.
Regulatory & Governance
Industry Regulations
Operations are dependent on obtaining and maintaining specific Governmental and Regulatory licenses and permits; failure to comply with these conditions adversely affects the ability to carry on business.
Environmental Compliance
Not disclosed in absolute INR; however, the company claims voluntary contribution to environmental spheres through CSR programs.
Taxation Policy Impact
Taxes and levies imposed by the Government of India or State Governments are cited as material risks to financial condition.
Legal Contingencies
Not disclosed in absolute INR; however, the company identifies 'major fraud' and 'lapses of internal control' as significant business risks.
Risk Analysis
Key Uncertainties
Narrowing margins in core trading products (-641% OPM variance), potential failure to renew regulatory licenses, and logistics errors in examination projects.
Third Party Dependencies
Dependency on an independent firm of Chartered Accountants for internal audits and reliance on government/regulatory bodies for operating licenses.
Technology Obsolescence Risk
The company identifies 'system failures' as a major risk to its examination management projects, suggesting a need for continuous digital transformation.
Credit & Counterparty Risk
Debtors Turnover Ratio improved by 22% to 2.16, indicating better collection efficiency despite overall losses.